Therapy specialization, medical advances, and changing markets have introduced more complexity in patient care. And with that complexity comes the opportunity for new approaches to product commercialization. This panel presentation explores the behavioral, logistical and financial challenges that accompany new classes of breakthrough therapies—and what all stakeholders must consider to drive optimal outcomes and success.